Immediate Administration of Zoledronic Acid Reduces Aromatase Inhibitor–Associated Bone Loss in Postmenopausal Women With Early Breast Cancer: 12-Month Analysis of the E-ZO-FAST TrialAntonio Llombart‐Cussac, Patrick Neven, Antonio Frassoldati et al.|Clinical Breast Cancer|2011Cited by 131
Treatment With Etirinotecan Pegol for Patients With Metastatic Breast Cancer and Brain MetastasesDebu Tripathy, Cláudia Vieira, Nuhad K. Ibrahim et al.|JAMA Oncology|2022Cited by 24